TTM
16.7%
YoY change
+2.43pp
Trough year (1998)
-88.4%
Peak year (2004)
27.2%
Latest annual
18.2%
FCF Margin history chart for Boston Scientific (BSX) from 1991 to 2025
Latest: 18.2%
FCF Margin change chart for Boston Scientific (BSX) from 1991 to 2025
Latest: +2.43pp
FCF Margin history table for Boston Scientific (BSX) from 1991 to 2025
| 2025 | 18.2% | +2.43pp | ||
| 2024 | 15.8% | +3.83pp | ||
| 2023 | 12.0% | +4.75pp | ||
| 2022 | 7.2% | -3.86pp | ||
| 2021 | 11.1% | -0.35pp | ||
| 2020 | 11.4% | -1.39pp | ||
| 2019 | 12.8% | +12.87pp | ||
| 2018 | -0.1% | -12.30pp | ||
| 2017 | 12.2% | +5.13pp | ||
| 2016 | 7.1% | +2.39pp | ||
| 2015 | 4.7% | -8.96pp | ||
| 2014 | 13.7% | +1.97pp | ||
| 2013 | 11.7% | -2.55pp | ||
| 2012 | 14.3% | +5.03pp | ||
| 2011 | 9.2% | +8.63pp | ||
| 2010 | 0.6% | -5.17pp | ||
| 2009 | 5.8% | -4.83pp | ||
| 2008 | 10.6% | +3.78pp | ||
| 2007 | 6.8% | -12.40pp | ||
| 2006 | 19.2% | +10.29pp | ||
| 2005 | 8.9% | -18.26pp | ||
| 2004 | 27.2% | +9.97pp | ||
| 2003 | 17.2% | -4.14pp | ||
| 2002 | 21.4% | +7.57pp | ||
| 2001 | 13.8% | -11.08pp | ||
| 2000 | 24.9% | +2.12pp | ||
| 1999 | 22.8% | +111.21pp | ||
| 1998 | -88.4% | -80.02pp | ||
| 1997 | -8.4% | -8.35pp | ||
| 1996 | -0.1% | +3.91pp | ||
| 1995 | -4.0% | -11.10pp | ||
| 1994 | 7.1% | -0.76pp | ||
| 1993 | 7.9% | -2.29pp | ||
| 1992 | 10.2% | +0.49pp | ||
| 1991 | 9.7% | — |
- 202518.2%+2.43pp
- 202415.8%+3.83pp
- 202312.0%+4.75pp
- 20227.2%-3.86pp
- 202111.1%-0.35pp
- 202011.4%-1.39pp
- 201912.8%+12.87pp
- 2018-0.1%-12.30pp
- 201712.2%+5.13pp
- 20167.1%+2.39pp
- 20154.7%-8.96pp
- 201413.7%+1.97pp
- 201311.7%-2.55pp
- 201214.3%+5.03pp
- 20119.2%+8.63pp
- 20100.6%-5.17pp
- 20095.8%-4.83pp
- 200810.6%+3.78pp
- 20076.8%-12.40pp
- 200619.2%+10.29pp
- 20058.9%-18.26pp
- 200427.2%+9.97pp
- 200317.2%-4.14pp
- 200221.4%+7.57pp
- 200113.8%-11.08pp
- 200024.9%+2.12pp
- 199922.8%+111.21pp
- 1998-88.4%-80.02pp
- 1997-8.4%-8.35pp
- 1996-0.1%+3.91pp
- 1995-4.0%-11.10pp
- 19947.1%-0.76pp
- 19937.9%-2.29pp
- 199210.2%+0.49pp
- 19919.7%—
FCF Margin values are taken from Boston Scientific's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About FCF Margin at Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported free cash flow margin is 16.7%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Boston Scientific (BSX) free cash flow margin is 18.22% – expanded 2.4 percentage points year-over-year.
The record annual free cash flow margin stands at 27.20%, reached in 2004; the historical low of -88.44% was recorded in 1998.
Boston Scientific FCF Margin by Year
Boston Scientific FCF Margin 2025: 18.2%
2025's free cash flow margin for Boston Scientific came in at 18.22%, expanded 2.4 percentage points from 2024.
Boston Scientific FCF Margin 2024: 15.8%
Boston Scientific posted free cash flow margin of 15.79% in 2024, expanded 3.8 percentage points from 2023.
Boston Scientific FCF Margin 2023: 12.0%
In 2023, Boston Scientific reported free cash flow margin of 11.96%, expanded 4.8 percentage points from 2022.
Boston Scientific FCF Margin 2022: 7.2%
Boston Scientific free cash flow margin in 2022 was 7.21%, contracted 3.9 percentage points from 2021.
Boston Scientific FCF Margin 2021: 11.1%
Boston Scientific free cash flow margin in 2021 was 11.07%.
See more financial history for Boston Scientific (BSX).
Sector peers by FCF Margin
Healthcare peers of Boston Scientific (BSX), ranked by their latest free cash flow margin
| 33.2% | |
| 23.1% | |
| 21.5% | |
| 18.8% | |
| 18.4% | |
| 15.1% | |
| 9.4% | |
| 4.4% |
- 33.2%
- 23.1%
- 21.5%
- 18.8%
- 15.1%
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation